Skip to main content
OpenTrials

Clinical trial condition

Ovarian Cancer

Explore clinical trials studying Ovarian Cancer. Study availability and eligibility vary by location and protocol.

1,442 public trials 325 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Cancer trial results

Recruiting

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

NCT04294927

Conditions
Adnexal Diseases, BRCA1 Gene Mutation, BRCA2 Gene Mutation, +18 more
Locations
  • UChicago Medicine Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Washington University Medical Center St Louis, Missouri, United States
View all 66 locations
View Trial Details
Recruiting

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery

NCT06290193

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +24 more
Locations
  • Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Recruiting

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

NCT05735080

Conditions
Adnexal Diseases, Advanced Cancer, Breast Cancer, +29 more
Locations
  • Florida Cancer Specialists Orlando, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
View all 18 locations
View Trial Details
Recruiting

A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer

NCT06888921

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
  • Northwestern Memorial Hospital Warrenville, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 28 locations
View Trial Details
Recruiting

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

NCT06395519

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, BRCA Mutation, +52 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 14 locations
View Trial Details
Recruiting

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

NCT07444814

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +30 more
Locations
  • University of Arkansas Little Rock, Arkansas, United States
  • UCLA - Hematology/Oncology Clinical Research Unit Los Angeles, California, United States
  • St. Francis Medical Center (OSF Healthcare) Peoria, Illinois, United States
  • START - Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

Avera Cancer Sequencing and Analytics Protocol (ASAP)

NCT05142033

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +51 more
Locations
  • Avera Cancer Institute - Marshall Marshall, Minnesota, United States
  • Avera Cancer Institute - Aberdeen Aberdeen, South Dakota, United States
  • Avera Cancer Institute - Mitchell Mitchell, South Dakota, United States
  • Avera Cancer Institute - Pierre Pierre, South Dakota, United States
View Trial Details

Related conditions